HOB Biotech Group (SHSE:688656) Issuance of Debt: ¥65.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688656 HOB Biotech Group Corp Ltd SHSE:688656
80 GF Score
Price ¥104.48
GF Value ¥94.98
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is HOB Biotech Group Issuance of Debt?

HOB Biotech Group SHSE:688656 -0.44% 80 Issuance of Debt is ¥65.0 Mil as of Jun. 2026. GuruFocus rates SHSE:688656 with a GF Score™ of 80/100 and a GF Value™ of ¥94.98 (Fairly Valued). The stock has 5 warning signs investors should review.

HOB Biotech Group's Issuance of Debt for the three months ended in Jun. 2026 was ¥10.0 Mil.

HOB Biotech Group's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was ¥65.0 Mil.

HOB Biotech Group Issuance of Debt Related Terms

HOB Biotech Group Issuance of Debt Historical Data

* Premium members only.

The historical data trend for HOB Biotech Group's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HOB Biotech Group Issuance of Debt Chart

HOB Biotech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.00 50.00 50.00 145.00 115.00

HOB Biotech Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.00 25.00 10.00 20.02 10.00
SHSE:688656
80GF Score
HOB Biotech Group Corp Ltd SHSE:688656
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HOB Biotech Group Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥65.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of ¥65.0 Mil mean?
HOB Biotech Group (SHSE:688656) has a Issuance of Debt of ¥65.0 Mil as of Jun. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on HOB Biotech Group and its competitors.
Is HOB Biotech Group's Issuance of Debt too high?
HOB Biotech Group's current Issuance of Debt is ¥65.0 Mil. Overall, HOB Biotech Group has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HOB Biotech Group's Issuance of Debt compare to ABT and SYK?
HOB Biotech Group's Issuance of Debt of ¥65.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Medical Devices & Instruments company?
A good Issuance of Debt depends on the Medical Devices & Instruments industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on HOB Biotech Group and its competitors. HOB Biotech Group's current Issuance of Debt is ¥65.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HOB Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, HOB Biotech Group (SHSE:688656) is currently considered Fairly Valued. The stock's GF Value™ is ¥94.98, compared to a current price of ¥104.48 — trading 10% above its estimated fair value. The current Issuance of Debt is ¥65.0 Mil. HOB Biotech Group's overall GF Score™ is 80/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For HOB Biotech Group (SHSE:688656), the current Issuance of Debt is ¥65.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HOB Biotech Group (SHSE:688656) Overvalued in 2026?

Based on GuruFocus' analysis, HOB Biotech Group stock appears to be overvalued. The current stock price of ¥104.48 is trading 10% above its estimated GF Value™ of ¥94.98. GuruFocus considers HOB Biotech Group to be Fairly Valued.

Key valuation signals for SHSE:688656:

  • Issuance of Debt: ¥65.0 Mil
  • GF Value™: ¥94.98 vs. price of ¥104.48 (10% above fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688656 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HOB Biotech Group Business Description

Address No. 218, Xinghu Street, Room 101, Building C6, Bio-Nano Park, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215009
HOB Biotech Group Corp Ltd is an in vitro diagnostic company. The firm is specialized in providing diagnostic tools to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care.
80GF Score

Get the complete analysis for SHSE:688656

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥104.48
Price
¥94.98
GF Value